Premium
Lung cancer in a health area of Spain: incidence, characteristics and survival
Author(s) -
GARCÍA PRIM J.M.,
GONZÁLEZ BARCALA F.J.,
PAZ ESQUETE J.,
POSE REINO A.,
FONDEVILA LÓPEZ A.,
VALDÉS CUADRADO L.
Publication year - 2010
Publication title -
european journal of cancer care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 67
eISSN - 1365-2354
pISSN - 0961-5423
DOI - 10.1111/j.1365-2354.2008.01008.x
Subject(s) - medicine , incidence (geometry) , lung cancer , stage (stratigraphy) , chemotherapy , retrospective cohort study , cancer , small cell carcinoma , basal cell , carcinoma , lung , surgery , oncology , paleontology , physics , optics , biology
GARCÍA PRIM J.M., GONZÁLEZ BARCALA F.J., PAZ ESQUEJE J., POSE REINO A., FONDEVILA LÓPEZ A. & VALDÉS CUADRADO L. (2010) European Journal of Cancer Care 19 , 227–233
Lung cancer in a health area of Spain: incidence, characteristics and survival To examine the incidence, characteristics, therapeutic approach and survival of diagnosed lung cancer (LC) in the Santiago de Compostela Health Area. A retrospective study was carried out on LC for a period of 3 years. Of the 481 cases collected, 92.7% were male. The median age was 66.93 years. The crude incidence for men and women was 80.71 and 5.84 per 100 000 inhabitants respectively. Among the non‐small cell lung cancers (NSCLC), 68.1% were diagnosed in stage IIIB or IV. The cancer had already spread in 62.2% of the small cell lung cancer (SCLC). Chemotherapy was used in 51.6% of patients. The survival probability from the first to the fifth year was 47.7%, 24.3%, 12.9%, 10% and 8.9% respectively. The median survival at 5 years was 12.12 months for NSCLC, rising to 29.8 months in stage I, and 8.85 months in SCLC. In our Health Area LC occurs more often in men, in whom the prevalence of smoking is very high. The most common histology type was squamous cell carcinoma. In the majority of cases, the diagnosis is made in the advanced stages, which accounts for the low percentage of surgical treatments and the short survival.